These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Autoimmune diseases of the liver and biliary tract and overlap syndromes in childhood. Maggiore G; Riva S; Sciveres M Minerva Gastroenterol Dietol; 2009 Mar; 55(1):53-70. PubMed ID: 19212308 [TBL] [Abstract][Full Text] [Related]
13. What is the association of primary sclerosing cholangitis with sex and inflammatory bowel disease in Turkish patients? Bayraktar Y; Arslan S; Saglam F; Uzunalimoglu B; Kayhan B Hepatogastroenterology; 1998; 45(24):2064-72. PubMed ID: 9951867 [TBL] [Abstract][Full Text] [Related]
14. Immunogenetic aspects of primary sclerosing cholangitis: implications for therapeutic strategies. van Milligen de Wit AW; van Deventer SJ; Tytgat GN Am J Gastroenterol; 1995 Jun; 90(6):893-900. PubMed ID: 7771416 [TBL] [Abstract][Full Text] [Related]
15. Endoscopic therapy in primary sclerosing cholangitis: outcome of treatment and risk of cancer. Linder S; Söderlund C Hepatogastroenterology; 2001; 48(38):387-92. PubMed ID: 11379315 [TBL] [Abstract][Full Text] [Related]
16. Primary sclerosing cholangitis: what are the nursing implications? Wilkinson MM Gastroenterol Nurs; 1992 Feb; 14(4):215-8. PubMed ID: 1623026 [TBL] [Abstract][Full Text] [Related]
17. Long-term treatment of primary sclerosing cholangitis in children with oral vancomycin: an immunomodulating antibiotic. Davies YK; Cox KM; Abdullah BA; Safta A; Terry AB; Cox KL J Pediatr Gastroenterol Nutr; 2008 Jul; 47(1):61-7. PubMed ID: 18607270 [TBL] [Abstract][Full Text] [Related]